These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1820900)

  • 21. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance thin-layer chromatographic method for the detection and determination of lansoprazole in human plasma and its use in pharmacokinetic studies.
    Pandya KK; Mody VD; Satia MC; Modi IA; Modi RI; Chakravarthy BK; Gandhi TP
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):199-204. PubMed ID: 9200535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.
    Tomilo DL; Smith PF; Ogundele AB; Difrancesco R; Berenson CS; Eberhardt E; Bednarczyk E; Morse GD
    Pharmacotherapy; 2006 Mar; 26(3):341-6. PubMed ID: 16503713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
    Ford SL; Wire MB; Lou Y; Baker KL; Stein DS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):467-9. PubMed ID: 15616339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an antacid on gastrointestinal absorption of theophylline.
    Arnold LA; Spurbeck GH; Shelver WH; Henderson WM
    Am J Hosp Pharm; 1979 Aug; 36(8):1059-62. PubMed ID: 484565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects.
    Doan TT; Wang Q; Griffin JS; Lukasik NL; O'Dea RF; Pan WJ
    Am J Health Syst Pharm; 2001 Aug; 58(16):1512-9. PubMed ID: 11515348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of food and various antacids on the absorption of tenoxicam.
    Day RO; Lam S; Paull P; Wade D
    Br J Clin Pharmacol; 1987 Sep; 24(3):323-8. PubMed ID: 3499163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole.
    Thoring M; Hedenström H; Eriksson LS
    Scand J Gastroenterol; 1999 Apr; 34(4):341-5. PubMed ID: 10365892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects.
    Patel G; Gupta VK; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0149522. PubMed ID: 36943038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules.
    Sharma VK; Ugheoke EA; Vasudeva R; Howden CW
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1171-4. PubMed ID: 9845407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lansoprazole: an alternative method of administration of a capsule dosage formulation.
    Chun AH; Eason CJ; Shi HH; Cavanaugh JH
    Clin Ther; 1995; 17(3):441-7. PubMed ID: 7585848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dose of antacid (Mylanta II) reduces bioavailability of ranitidine.
    Mihaly GW; Marino AT; Webster LK; Jones DB; Louis WJ; Smallwood RA
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):998-9. PubMed ID: 6289961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.
    Baldi F; Malfertheiner P
    Digestion; 2003; 67(1-2):1-5. PubMed ID: 12743433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteers.
    Wong SL; Linnen P; Mack R; Granneman GR
    Biopharm Drug Dispos; 1997 Aug; 18(6):533-41. PubMed ID: 9267685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states.
    Tobert JA; DeSchepper P; Tjandramaga TB; Mullie A; Buntinx AP; Meisinger MA; Huber PB; Hall TL; Yeh KC
    Clin Pharmacol Ther; 1981 Sep; 30(3):385-9. PubMed ID: 7023791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate.
    Sharma VK; Peyton B; Spears T; Raufman JP; Howden CW
    Aliment Pharmacol Ther; 2000 Jul; 14(7):887-92. PubMed ID: 10886044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of lansoprazole in hemodialysis patients.
    Karol MD; Machinist JM; Cavanaugh JM
    J Clin Pharmacol; 1995 Aug; 35(8):815-20. PubMed ID: 8522639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography.
    Karol MD; Granneman GR; Alexander K
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):182-6. PubMed ID: 7550976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube.
    Chun AH; Shi HH; Achari R; Dennis S; Cavanaugh JH
    Clin Ther; 1996; 18(5):833-42. PubMed ID: 8930427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.